INVITRO DISSOLUTION OF SOME COMMERCIALLY AVAILABLE SUSTAINED-RELEASE THEOPHYLLINE PREPARATIONS

被引:15
作者
BUCKTON, G
GANDERTON, D
SHAH, R
机构
关键词
D O I
10.1016/0378-5173(88)90157-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:35 / 39
页数:5
相关论文
共 7 条
[1]  
GOODMANGILMAN A, 1980, PHARM BASIS THERAPEU, P592
[2]   COMPARISON STUDY OF SUSTAINED-RELEASE THEOPHYLLINE PRODUCTS - SLO-BID CAPSULES VERSUS THEO-DUR TABLETS IN 20 CHILDREN AND YOUNG-ADULTS WITH ASTHMA [J].
HANNAWAY, PJ ;
HOPPER, GDK .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 77 (03) :456-464
[3]   STUDIES ON THE DELIVERY MECHANISMS OF THEOPHYLLINE FROM A SUSTAINED-RELEASE TABLET [J].
LAGAS, M ;
JONKMAN, JHG .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (04) :489-506
[4]   THE BIOAVAILABILITY, ABSORPTION CHARACTERISTICS AND FORMULATION OF 4 COMMERCIALLY-AVAILABLE CONTROLLED-RELEASE THEOPHYLLINE PRODUCTS [J].
SUMMERS, RS ;
SUMMERS, B ;
RAWNSLEY, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 30 (01) :83-88
[5]  
VOGEL AI, 1972, TXB MACRO SEMIMACRO, P52
[6]   RELATIONSHIP OF FORMULATION AND DOSING INTERVAL TO FLUCTUATION OF SERUM THEOPHYLLINE CONCENTRATION IN CHILDREN WITH CHRONIC ASTHMA [J].
WEINBERGER, M ;
HENDELES, L ;
WONG, L .
JOURNAL OF PEDIATRICS, 1981, 99 (01) :145-152
[7]   ORAL CONTROLLED DRUG ADMINISTRATION - PHARMACOKINETIC CONSIDERATIONS [J].
WELLING, PG .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1983, 9 (07) :1185-1225